Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports ...

Shares in drug giant Moderna ($MRNA) were over 5% healthier today after Canada said yes to its Covid vaccine. Health Canada ...

All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...

The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...

Moderna’s stock slumped 3.2% toward a six-week low in afternoon trading. It has now tumbled 23.3% since closing at a four-month high two weeks ago, highlighted by an 8.1% drop on July 31 after the ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at therapeutics stocks, starting with ...

Moderna, Inc. (NASDAQ:MRNA) stands fifth among the best cancer stocks. It is best known for its mRNA COVID-19 vaccine and is expanding into oncology with a focus on personalized cancer immunotherapies ...

The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a ...

In a note to employees Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the biotechnology company’s plan to cut annual costs by $1.5 billion over the next ...

Key Points Moderna has struggled since COVID-19 vaccine demand has shrunk. The stock has correspondingly declined, as revenue has nosedived over the last few years. The long game is clinical ...